6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Ubunyulu ≥99.0% Favipiravir Intermediate COVID-19

Inkcazelo emfutshane:

Igama: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

CAS: 259793-88-9

Ubunyulu: ≥99.0%

Umbindi weFavipiravir (CAS 259793-96-9) kunyango losulelo lwentsholongwane ye-Influenza kunye ne-COVID-19

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Umenzi onobunyulu obuPhezulu kunye noMgangatho oZinzile
Ubonelelo ngezoRhwebo lweFavipiravir kunye nabaPhakathi abaNxulumeneyo:
IFavipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
I-3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Iipropati zeMichiza:

Igama leMchiza	I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide
Izithethantonye	IFavipiravir ePhakathi;Ukungacoceki kweFavipiravir 4
Inombolo yeCAS	259793-88-9
Inombolo yeCAT	RF-PI296
Ubume beStokhwe	Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli	I-C5H4BrN3O2
Ubunzima beMolekyuli	218.01
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umthubi oKhanyayo ukuya kumgubo oBrown
Ukuchongwa	IR, HPLC
Ilahleko ekomisweni	≤1.0%
Intsalela kwi-Ignition	≤0.20%
Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤1.0%
Iintsimbi ezinzima	≤20ppm
Izinyibilikisi ezishiyekileyo	Hlangana nenkcazo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi weFavipiravir (CAS 259793-96-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) yindawo ephakathi ngokuqhelekileyo kwi-synthesis ye-6-Bromo-3-Hydroxypyrazine-2-Carboxamide ebizwa ngokuba yiFavipiravir (CAS 259793-96-9) unyango losulelo lwe-influenza virus.Indlela esebenzayo kunye nenyathelo loqoqosho kwiFavipiravir.IFavipiravir yimveliso yophando enxulumene ne-COVID19, kunyango lwezigulana ezine-COVID-19 ecetyiswa yi-WHO.I-Favipiravir, ekwaziwa ngokuba yi-T-705 okanye i-Avigan, lichiza le-antiviral eliphuhliswa yi-Toyama Chemical (iQela le-Fujifilm) lase-Japan elisebenza ngokuchasene neentsholongwane ezininzi ze-RNA.I-Favipiravir yavunywa ukuba ithengiswe eJapan ngo-Matshi 2014 kwaye isetyenziselwa unyango lwe-antiviral ye-influenza A kunye ne-B. Ukongeza kwintsholongwane yomkhuhlane, iyeza libonise umsebenzi omhle we-antiviral kwiindidi ze-RNA, ezifana ne-Ebola virus, intsholongwane yesanti, Intsholongwane yeBunia, intsholongwane yomgada, njalo njalo. NgoFebruwari ka-2020 iFavipiravir yayifundelwa e-China kuvavanyo lonyango lwe-COVID-19 (iNovel Coronavirus) isifo kwaye ineziphumo ezincumisayo.